Cargando…
Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and the association with other autoimmune diseases is well-documented. There are many therapeutic options for the treatment of MS. Most of the available drugs cause drug-induced liver injury (DILI) to variable e...
Autores principales: | Meunier, Lucy, Larrey, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821303/ https://www.ncbi.nlm.nih.gov/pubmed/36614299 http://dx.doi.org/10.3390/ijms24010852 |
Ejemplares similares
-
Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019) -
Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs
por: Teschke, Rolf, et al.
Publicado: (2016) -
Immunotherapy and Gene Therapy: New Challenges in the Diagnosis and Management of Drug-Induced Liver Injury
por: Delire, Bénédicte, et al.
Publicado: (2022) -
Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same
por: Olry, Alexandre, et al.
Publicado: (2020) -
HLA-class I markers and multiple sclerosis susceptibility in the Italian population
por: Bergamaschi, L, et al.
Publicado: (2009)